1. 679: Effect of Moderate Hepatic Impairment on the Safety and Pharmacokinetics of Rezafungin. (January 2021) Authors: Ong, Voon; Sandison, Taylor; Melara, Rebeca; Marbury, Thomas; Huguet, Jade; Jandourek, Alena; Flanagan, Shawn Journal: Critical care medicine Issue: Volume 49:Supplement 1 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Phase I, Randomized, Placebo-Controlled, 3-Day, Ascending-Dose Study of Gs-9451, An Ns3/4A Protease Inhibitor, in Genotype 1 Hepatitis C Patients. Issue 3 (April 2013) Authors: Lawitz, Eric J; Hill, John M; Marbury, Thomas; DeMicco, Michael P; Delaney, William; Yang, Jenny; Moorehead, Lisa; Mathias, Anita; Mo, Hongmei; McHutchison, John G; Rodriguez-Torres, Maribel; Gordon, Stuart C Journal: Antiviral therapy Issue: Volume 18:Issue 3(2013) Page Start: 311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Single-Dose, Open-Label Study of the Pharmacokinetics, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Individuals With Normal and Impaired Renal Function. Issue 4 (August 2016) Authors: Ermer, James; Corcoran, Mary; Lasseter, Kenneth; Marbury, Thomas; Yan, Brian; Martin, Patrick T. Journal: Therapeutic drug monitoring Issue: Volume 38:Issue 4(2016:Aug.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Cabozantinib. (23rd March 2016) Authors: Nguyen, Linh; Holland, Jaymes; Ramies, David; Mamelok, Richard; Benrimoh, Natacha; Ciric, Sabrina; Marbury, Thomas; Preston, Richard A.; Heuman, Douglas M.; Gavis, Edith; Lacy, Steven Journal: Journal of clinical pharmacology Issue: Volume 56:Number 9(2016) Page Start: 1130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Elagolix Pharmacokinetic Profiles in Women With Renal or Hepatic Impairment. Issue 8 (20th December 2018) Authors: Ng, Juki; Duan, W. Rachel; Marbury, Thomas; Schmidt, Jeffrey M.; Klein, Cheri E. Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 8(2019) Page Start: 1053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Evaluation of the Pharmacokinetics and Safety of a Single Dose of Acalabrutinib in Subjects With Hepatic Impairment. (15th February 2022) Authors: Xu, Yan; Izumi, Raquel; Nguyen, Helen; Kwan, Anna; Kuo, Howard; Madere, Jeannine; Slatter, J. Greg; Podoll, Terry; Vishwanathan, Karthick; Marbury, Thomas; Smith, William; Preston, Richard A.; Sharma, Shringi; Ware, Joseph A. Journal: Journal of clinical pharmacology Issue: Volume 62:Number 6(2022) Page Start: 812 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin. Issue 5 (23rd January 2020) Authors: Bhagunde, Pratik; Colon‐Gonzalez, Francheska; Liu, Yang; Wu, Jin; Xu, Shiyao Sherrie; Garrett, Graigory; Jumes, Patricia; Lasseter, Kenneth; Marbury, Thomas; Rizk, Matthew L.; Lala, Mallika; Rhee, Elizabeth G.; Butterton, Joan R.; Boundy, Keith Journal: British journal of clinical pharmacology Issue: Volume 86:Issue 5(2020) Page Start: 944 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Moderate Hepatic Impairment Does Not Affect Doravirine Pharmacokinetics. (27th December 2016) Authors: Khalilieh, Sauzanne; Yee, Ka Lai; Liu, Rachael; Fan, Li; Sanchez, Rosa I.; Auger, Patrice; Triantafyllou, Ilias; Stypinski, Daria; Lasseter, Kenneth C.; Marbury, Thomas; Iwamoto, Marian Journal: Journal of clinical pharmacology Issue: Volume 57:Number 6(2017) Page Start: 777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate hepatic impairment. (June 2014) Authors: Venkatakrishnan, Karthik; Liu, Yi; Noe, Dennis; Mertz, Jaime; Bargfrede, Michael; Marbury, Thomas; Farbakhsh, Kambiz; Oliva, Cristina; Milton, Ashley Journal: British journal of clinical pharmacology Issue: Volume 77:Number 6(2014:Jun.) Page Start: 998 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate renal impairment. (June 2014) Authors: Venkatakrishnan, Karthik; Liu, Yi; Noe, Dennis; Mertz, Jaime; Bargfrede, Michael; Marbury, Thomas; Farbakhsh, Kambiz; Oliva, Cristina; Milton, Ashley Journal: British journal of clinical pharmacology Issue: Volume 77:Number 6(2014:Jun.) Page Start: 986 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗